These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15781431)

  • 1. Management of mixed hyperlipidaemia.
    Stalenhoef AF
    Eur Heart J; 2005 May; 26(9):856-7. PubMed ID: 15781431
    [No Abstract]   [Full Text] [Related]  

  • 2. [How sure is the combined lipid lowering?].
    Schäfer J
    MMW Fortschr Med; 2005 Jan; 147(1-2):56. PubMed ID: 15704576
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia.
    McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B
    J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis (the SEAS trial).
    Farmer JA
    Curr Atheroscler Rep; 2009 Mar; 11(2):82-3. PubMed ID: 19228479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Statin plus niacin or ezetimibe? What combination for which patients?].
    Parhofer K
    MMW Fortschr Med; 2009 Dec; 151(49-50):16. PubMed ID: 20085070
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ezetimib--the first selective cholesterol resorption inhibitors. Strengthening of statins].
    MMW Fortschr Med; 2002 Nov; 144(48):52-3. PubMed ID: 12532546
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical inquiries. What are effective medication combinations for dyslipidemia?
    Saseen J; Tweed E; Crawford P
    J Fam Pract; 2006 Jan; 55(1):70-2. PubMed ID: 16388773
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.
    Farnier M; Roth E; Gil-Extremera B; Mendez GF; Macdonell G; Hamlin C; Perevozskaya I; Davies MJ; Kush D; Mitchel YB;
    Am Heart J; 2007 Feb; 153(2):335.e1-8. PubMed ID: 17239698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ezetimibe coadministered with fenofibrate: some safety questions.
    Borja J
    Eur Heart J; 2005 Nov; 26(21):2344; author reply 2344. PubMed ID: 16123048
    [No Abstract]   [Full Text] [Related]  

  • 10. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia.
    Kastelein JJ; Sankatsing RR
    Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [When should an association of lipid-lowering drugs be proposed in a patient failing to reach therapeutic targets under monotherapy? Guidelines of the New French Society of Atherosclerosis].
    Farnier M; Bonnet F; Bruckert E; Ferrières J; Paillard F;
    Arch Mal Coeur Vaiss; 2007; 100(6-7):569-81. PubMed ID: 17893640
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Westerink J; Visseren FL
    Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Settergren M; Rydén L; Pernow J
    Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944
    [No Abstract]   [Full Text] [Related]  

  • 14. Targeting vascular risk in patients with metabolic syndrome but without diabetes.
    Athyros VG; Mikhailidis DP; Papageorgiou AA; Didangelos TP; Peletidou A; Kleta D; Karagiannis A; Kakafika AI; Tziomalos K; Elisaf M
    Metabolism; 2005 Aug; 54(8):1065-74. PubMed ID: 16092057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation".
    Tershakovec AM; Veltri EP; Pasternak RC
    Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ezetimib--a new possibility for combined therapy in hypercholesterolemia].
    Kvapil M
    Vnitr Lek; 2004 Aug; 50(8):643-4. PubMed ID: 15521210
    [No Abstract]   [Full Text] [Related]  

  • 17. Fenofibric Acid (trilipix).
    Med Lett Drugs Ther; 2009 May; 51(1311):33-4. PubMed ID: 19417718
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combination pharmacotherapy therapy in the management of atherogenic dyslipidemia].
    Kłosiewicz-Latoszek L; Cybulska B
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II76-80. PubMed ID: 19813341
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of ezetimibe.
    Ashikaga H; Blumenthal RS; Jones SR
    Am J Cardiol; 2009 May; 103(9):1321-2. PubMed ID: 19406279
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy.
    Unnikrishnan R; Das R; Jaydip R; Sudhakaran C; Mohan V
    J Assoc Physicians India; 2009 Feb; 57():180-1. PubMed ID: 19582991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.